The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice

[1] Abdrakhmanova GR(2006)2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal α4β2 nAChRs Mol Pharmacol 69 1945-1952

[2] Damaj MI(1996)Nicotine cue: lack of effect of the α7 niconic receptor antagonist methyllycaconitine Eur J Pharmacol 301 1-5

[3] Carroll FI(1997)Discriminative stimulus properties of the nicotinic agonist cytisine Psychopharmacology 129 257-264

[4] Martin BR(1999)Drug discrimination in neurobiology. Biochem Behav 64 337-345

[5] Brioni JD(1984)Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization J Pharmacol Exp Ther 230 193-199

[6] Kim DJ(2011)The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation Eur J Pharmacol 654 47-52

[7] O’Neill AB(2013)Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids Psychopharmacology 228 321-333

[8] Chandler CJ(2016)Differential antagonism and tolerance/cross-tolerance among nicotinic acetylcholine receptor agonists: scheduled-controlled responding and hypothermia in C57BL/6J mice Behav Pharmacol 27 240-248

[9] Stolerman IP(2010)Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds J Pharmacol Exp Ther 335 807-816

[10] Colpaert FC(1989)Discrimination of a drug mixture in rats: role of training dose, and specificity Behav Pharmacol 1 25-31

[1] Abdrakhmanova GR(2006)2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal α4β2 nAChRs Mol Pharmacol 69 1945-1952

[2] Damaj MI(1996)Nicotine cue: lack of effect of the α7 niconic receptor antagonist methyllycaconitine Eur J Pharmacol 301 1-5

[3] Carroll FI(1997)Discriminative stimulus properties of the nicotinic agonist cytisine Psychopharmacology 129 257-264

[4] Martin BR(1999)Drug discrimination in neurobiology. Biochem Behav 64 337-345

[5] Brioni JD(1984)Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization J Pharmacol Exp Ther 230 193-199

[6] Kim DJ(2011)The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation Eur J Pharmacol 654 47-52

[7] O’Neill AB(2013)Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids Psychopharmacology 228 321-333

[8] Chandler CJ(2016)Differential antagonism and tolerance/cross-tolerance among nicotinic acetylcholine receptor agonists: scheduled-controlled responding and hypothermia in C57BL/6J mice Behav Pharmacol 27 240-248

[9] Stolerman IP(2010)Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds J Pharmacol Exp Ther 335 807-816

[10] Colpaert FC(1989)Discrimination of a drug mixture in rats: role of training dose, and specificity Behav Pharmacol 1 25-31